Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0HOJ market cap is 5.24B. The company's latest EPS is USD -1.0561 and P/E is -84.96.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 793.74M | 180.08M | 204.04M | 249.38M | 508.82M |
| Operating Income | 308.71M | -641.98M | -537.52M | -486.28M | -212.04M |
| Net Income | 313.88M | -644.09M | -557.52M | -506.98M | -67.09M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.72B | 1.25B | 1.35B | 1.05B | 1.18B |
| Total Liabilities | 248.31M | 281.49M | 835.23M | 918.64M | 881.15M |
| Total Equity | 1.47B | 970.74M | 514.68M | 130.61M | 298.67M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 387.04M | -298.65M | -502.28M | -436.85M | -192.59M |
| Investing | -434.25M | -225.86M | -149.54M | 274.04M | -47.5M |
| Financing | 617.76M | 50.72M | 561.81M | 119.23M | 273.11M |
| Market Cap | 5.24B |
| Price to Earnings Ratio | -84.96 |
| Price to Sales Ratio | 11.2 |
| Price to Cash Ratio | 55.88 |
| Price to Book Ratio | 19.09 |
| Dividend Yield | - |
| Shares Outstanding | 63.53M |
| Average Volume (1 week) | 5 |
| Average Volume (1 Month) | 47 |
| 52 Week Change | 0.00% |
| 52 Week High | 82.54 |
| 52 Week Low | 82.54 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Blueprint Medicines Corp |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.blueprintmedicines.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
